Ultomiris 300 mg/30mL (Ravulizumab SOLUTION, CONCENTRATE) 300 mg/30mL

Ultomiris 300 mg/30mL is a pharmaceutical solution used for specific medical conditions. This intravenous concentrate is manufactured by Alexion Pharmaceuticals Inc. and is available in a 30mL vial.

Strength

300 mg/30mL

Pack Size

1 VIAL, GLASS in 1 CARTON (25682-022-01) / 30 mL in 1 VIAL, GLASS

Manufacturer / TM Owner

Alexion Pharmaceuticals Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ultomiris 300 mg/30mL is a medication that contains ravulizumab, a monoclonal antibody. It is primarily used to manage certain conditions related to the complement system, which is part of the immune system. The drug is often prescribed for conditions where the complement system is overactive, leading to damage in the body. What is Ultomiris used for? It is typically used in the treatment of conditions like paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).

Side Effects

Common effects of Ultomiris 300 mg/30mL may include infusion-related reactions such as headache, nausea, and fatigue. Some individuals might experience upper respiratory tract infection, diarrhea, and back pain. These effects can vary from person to person and are not exhaustive. Always consult a healthcare provider for personalized information.

Precautions & Warnings

Ultomiris 300 mg/30mL should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. The solution should be stored and administered under proper medical supervision. Patients should inform their healthcare provider about any allergies or medical conditions before starting treatment.

Avoid Interactions

Ultomiris 300 mg/30mL may interact with other medications, including those that affect the immune system. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain foods might also interact with the drug, so it is advisable to follow medical advice regarding lifestyle adjustments during treatment.

Frequently Asked Questions

Ultomiris is used to manage conditions related to the complement system, such as paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).

Ultomiris is administered intravenously by a healthcare professional. It comes as a concentrate that is diluted before use.

Common side effects may include headache, nausea, fatigue, upper respiratory tract infection, diarrhea, and back pain.

Ultomiris may interact with other medications, so it is important to discuss all current medications with a healthcare provider.

Ultomiris should be stored as per the instructions provided by the manufacturer and healthcare provider, typically under refrigeration.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.